The military software market dominates due to rising global defense budgets, growing reliance on advanced technologies, and the need for enhanced situational awareness and cybersecurity. Nations are increasingly adopting AI, automation, and secure communication systems to modernize military operations, improve decision-making, and protect critical infrastructure against evolving threats Allied Market Research published a report, titled,”Military […]

NEW YORK, NY / ACCESS Newswire / October 30, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=174736&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

(NASDAQ:ABEO), CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the Centers for Medicare and Medicaid Services (CMS) has established a permanent Healthcare Common Procedure Coding System (HCPCS) J-code for ZEVASKYN (prademagene zamikeracel) gene-modified cellular sheets, the

Abeona Therapeutics(R) Announces Permanent J-Code for ZEVASKYN(R) (prademagene zamikeracel) GlobeNewswire October 30, 2025 CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the Centers for Medicare and Medicaid Services (CMS) has established a permanent Healthcare Common Procedure

Indegene Selects Verified Market Research to Gain Strategic Insight into the Conjunctivitis Allergy Market Indegene, a global healthcare solutions company specialising in digital-first commercialization services for biopharma, emerging biotech and medical device companies, has partnered with Verified Market Research (VMR) to access decision-grade insights on the Global Conjunctivitis Allergy Market Size, Scope and Forecast report.

NEW YORK, NY / ACCESS Newswire / October 30, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=174742&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

(NYSE:TROX),(NasdaqGM:QMCO),(NASDAQ:SVRA),(NASDAQ:FLYE), ATLANTA, Oct. 30, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Quantum Corp. (QMCO) The shareholder class action lawsuit filed against Quantum Corporation (“Quantum” or the “Company”) (NASDAQ: QMCO) alleges that Defendants made materially false and/or

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Quantum Corporation (QMCO), Tronox Holdings plc (TROX), Fly-E Group, Inc. (FLYE), and Savara Inc. (SVRA) GlobeNewswire October 30, 2025 ATLANTA, Oct. 30, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to

Cincinnati, OH – April ABA Therapy In Ohio: ABA Therapy Ohio is a leading provider of Applied Behavior Analysis (ABA) therapy. The company is expanding its services across a multi-state region to better meet the increasing demand for quality autism care. With a mission to provide compassionate ABA Therapy, the company now extends its reach

Brooklyn, NY – Dry Ease Mold Removal is a leading provider of mold remediation services. The company is pleased to announce the expansion of its comprehensive mold removal solutions in Brooklyn, New York, in response to the increasing requests from property owners throughout New York City. This expansion reflects Dry Ease Mold Removal’s commitment to